[4; 5].
-
-
,
[6-10].
,
-
-
,
47
1.
(
),
(
)
(
)
-2
(
)
-2
(
-
)
(
-
)
.
,
-2
(
) [15; 16],
-2
-
(
7
)
(
)
Medata
Holter ECG tracer (SN MEBA 734744 (USA)
(V
3
, V
5
VF)
S-T
[17; 18].
-
-
Excel 2007 [3].
-
( )
(m);
-
( ),
(SD)
(SE),
,
-
,
-
2
.
.
r
0,25-0,35
,
r 0,36-
0,70 -
,
r - 0,71 0,99 -
.
-
t-
.
<0,05.
-
.
-
-
(
)
-
(
)
-
1.
1.
-
(
)
(
)
-2 (n = 73)
-2 (n = 86)
(n = 49)
(n = 24)
(n = 52)
(n = 34)
< 9
15 (9,43%)
6 (3,77%)
1/2
26 (16,35%)
20 (12,58%)
1/2
21
(13,21%)
1/2
46
(28,93%)
1/2
> 9
34 (21,38%)*
18 (11,32%)*
30 (18,87%)
17 (10,69%)
52 (32,7%)
40 (25,16%)
34 (21,38%)
28 (17,61%)
30 (18,87%)
17 (10,69%)
62
(38,99%)
1/2
29
(18,24%)
1/2
( / )
22 (13,84%)
19 (11,95%)
1/2
13 (8,18%)
8 (5,03%)
1/2
41 (25,79%)
21 (13,21%)
( / )
12 (7,55%)
9 (5,66%)
6 (3,77%)
2 (1,26%)
21
(13,21%)
1/2
8
(5,03%)
1/2
:
1/2
–
-2
(
-2) (p<0,05);
* –
(p<0,05)
0
39
38
28
3
1
-73
+
.
-n=49
n=24
44
34
21
1
0
+
.
-86
48
1,
-2,
,
9
-2 (p<0,05).
-
-2.
-
-2.
-
2.
2,
,
-
,
,
15 60
.
-
.
-
-2
(
-
-
-
),
(
-2)
-
(
).
-
-
-
,
-
,
,
-
-
-2,
-
(
-2)
.
,
,
,
-
.
-
(
9%)
-
.
-
(
)
-
,
-
-2
(
-2)
.
3.
2.
( %-
)
(M + m)
-2
(
) (
-2)
-2 (n = 73)
(n = 86)
(n = 49)
(n = 24)
(n = 52)
(n = 34)
3,21 + 0,27
(2,7 – 3,7)
3,25 + 0,25
(2,8 – 3,7)
3,21 + 0,29
(2,7 – 3,7)
3,39 + 0,29
(2,7 – 3,9)
3,22
+ 0,27 (2,7 – 3,7)
3,31 + 0,31 (2,7 – 3,9)
(%)
15
6,95
+ 1,21
(1/2)
(3,71 – 11,19)
6,39 + 0,81
(1/2)
(4,93 – 9,91)
10,31 + 0,98
(1/2)
(7,3-13,6)
9,21 + 0,81
(1/2)
(7,2–12,8)
6,76
+ 1,07 (3,7 – 11,19)
(1/2)
9,78
+ 0,99 (7,2 – 13,6)
(1/2)
60
8,33
+ 0,97
(1/2)
(6,22 – 10,42)
7,61 + 0,89
(1/2)
(6,27 – 9,55)
14,51 + 0,88
(1/2)
(9,53 – 19,52)
16,77 + 0,96
(1/2)
(8,98 – 21,14)
8,07
+ 0,99 (6,22 – 10,42)
(1/2)
15,85
+ 0,99 (8,98 – 21,14)
(1/2)
:
(1/2)
–
-2
;
–
;
–
%-
49
3.
( +m)
-2
(
)
-2
: 159 (100%)
: n = 101 (63,52%)
: n = 58 (36,48%)
-2 (n
-2
= 73; n
= 49; n
= 24)
(n = 86; n
= 52; n
=
34)
-2 +
(n = 39)
-2
(n = 34)
+
(n = 44)
(n = 42)
63,48 + 8,12
(27 - 75)
56,41 + 7,82
(27 - 67)
61,75 + 7,14
(44 - 81)
56,54 + 6,58
(44 - 69)
59,52 + 9,13 (27 - 75)
58,99 + 7,23 (44 - 81)
: n
-2
–
-2; n –
; n –
; n –
;
-2+
-
-2
(
);
-2
-
-2
;
+
-
;
-
3,
.
-
,
-
-
,
-
-
-
-2 +
,
(
2) –
-
.
,
-
-
-2,
,
,
-
,
-
,
-
-
,
-
-
,
–
-
-2
-2
-
.
-
-
(
)
(
-
)
-
,
,
-1
-
-
,
-
.
-
,
-1
,
,
,
(
4).
-
-
-
,
-
,
,
-1
–
(r=-0,7843, p<0,01;
r=-0,7214, p<0,05,
).
ST
7-
,
ST
-2
-2 (
5).
5,
-2
ST:
(p<0,05).
,
,
-2
-
50
4.
(
)
-1 (
-1) (M+m)
(n = 85)
(n = 74)
(n = 53)
(n=32)
n = 48)
(n = 26)
,
/ 8,73
+ 2,25
(5,4 – 12,56)
1/2
9,44 + 2,73
(6,2 – 18,4)
1/2
16,25 + 2,79
(6,5 – 36,8)
1/2
17,32 + 2,67
(6,6 – 38,4)
1/2
9,07
+ 2,74 (5,4 – 18,4)
1/2
16,86
+ 2,35 (6,5 – 38,4)
1/2
-1,
/
7,63 + 1,45
(6,11 – 9,56)
1/2
8,91 + 1,76
(6,22–9,65)
1/2
11,97 + 1,37
(6,93 – 12,82)
1/2
13,61 + 1,04
(6,99–14,24)
1/2
7,46
+ 1,78 (6,11 – 9,65)
1/2
12,74
+ 1,92 (6,93 – 14,24)
1/2
:
1/2
–
(p<0,001)
5.
ST
-2
(
)
-2
-2 (n = 73)
(n = 84)
(n = 49)
(n = 24)
(n = 52)
(n = 34)
ST
136 (85,53%)
1/2
142
(89,31%)
1/2
64
(40,25%)
1/2*
33
(20,75%)
1/2*
278
(174,84%)
1/2
97
(61,0%)
1/2
:
ST –
ST
; 1/2 –
-2
(
-2) (p<0,05); * -
(p<0,05)
,
-2,
,
-
.
-2
-
,
-
,
-
-
,
.
1.
-2
-
,
-
(
)
-
,
-2
,
-
-
;
2.
-
(
)
-1( -1)
,
-
-
-1
(r=-0,7843,
p<0,01; r=-0,7214, p<0,05,
).
;
3.
-
(
-
)
-
-
-
(
ST
-
278
-2
97
.
51
1.
Goraya T.Y., Leibson C.L., Palumbo P.J. et al. Coronary atherosclerosis in diabetes mellitus: a
population-based autopsy study / J. Am. Coll. Cardiol. – 2002. – Vol. 40 (5). – pp. 946-953.
2.
Haffner S.M., D'Agostino R.Jr., Saad M.F. et al. Carotid artery atherosclerosis in type 2 diabetic and
nondiabetic subjects with and without symptomatic coronary artery disease (The insulin resistance
atherosclerosis study) / Am. J. Cardiol. – 2000. – Vol. 85. – p. 1395-1400.
3.
Stout R.W. Diabetes, atherosclerosis and aging / Diabetes Care. – 1990. – Vol. 13 (Suppl. 2). – pp. 20-
23.
4.
. .
2
.
.
.
.
.
– 2008. – 240 .
5.
. .,
. .
. /
/
. . .
(IV
, . XI) // . –
. – 1997. – c. 195-210.
6.
. .,
. .,
. .
.
(
2339312,
: 27.11.2008)
7.
. .
-
.
.
.
.
.
- -
. – 2006. – 346 .
8.
Celermajer D.S. Testing endothelial function using ultrasound / J. Cardiovasc. Pharmacol. – 1998. –
Vol. 32 (Suppl 3). – pp. S29-32.
9.
Graham M., Daly L., Refsum H. et al. Plasma homocysteine as a risk factor for vascular disease: the
European concerted action project / J.A.M.A. – 1997. – Vol. 277 (22). – pp. 1775-1781.
10. Hankey G.J., Eikelboom J.W. Homocysteine and vascular disease / Lancet. – 1999. – Vol. 354. – pp.
407-413.
11. Luscher T.F., Creager M.A., Beckman J.A. et al. Diabetes and vascular disease: pathophysiology,
clinical consequences, and medical therapy: Part II / Circ. – 2003. – Vol. 108 (13). – pp. 1655-1661.
12. Yamasaki Y., Kodama M., Nishizawa H. et al. Carotid intima-media thickness in Japanese type 2
diabetic subjects: predictors of progression and relationship with incident coronary heart disease /
Diabetes. Care. – 2000. – Vol. 23 (1310). – p. 1315.
13.
. .
:
(
2) / htpp:// the-filithlivejournal.com/175391.html
14. World Health Organization. Definition, diagnosis and classification of diabetes mellitus and its
complications / Report of a WHO Consultation. – 1999. – 59 P.
15. Cohn P.F., Kannel W.B. Recognition, pathogenesis, and management options in silent coronary artery
disease / Circ. – 1987. – Vol. 75. – p. 11-15.
16. Stone P.H., Chaitman B.R., McMahon R.P. et al. The Asymptomatic Cardiac Ischemia Pilot (ACIP)
Study: relationship between exercise induced and ambulatory ischemia in patients with stable coronary
disease / Circ. – 1996. – Vol. 94. – pp. 1537-1544.
17. Crawford M.H., Bernstein S.J., Deedwania P.C. et al. ACC/AHA guidelines for ambulatory
electrocardiography: a report of the American College of Cardiology/ American Heart Association Task
Force on Practice Guidelines (Committee to Revise the Guidelines for Ambulatory
Electrocardiography) // J. Am. Coll. Cardiol. – 1999. – Vol. 34. – pp. 912-948.
18. Kodama Y. Evalution of myocardial ischemia using Holter monitoring / Fukuoka-Igaku-Zasshi. – 1995.
– Vol. 86 (7). – pp. 304-316.
52
Gurbanov Y.Z., Abbasova M.R, Rzayeva R.A., Novruzova M.S.
Comparison of common carotid artery vascular pool condition with ischemic heart disease
manifestation homocysteine exchange, vasomotor and productive activity of endothelium in
patients with and without diabetes mellitus type 2
Department of Terapevtic and pediatric propedeutic, Azerbaijan Medical University, Baku
Summary. In this article the results of the morphological-structural investigation of common,
internal and external carotid arteries in comparison with simultaneously determined plasma levels
of homocysteine, vasomotor, productive activity of endothelium and manifestations of ischemic
heart disease (estimated by shifts of ST segment during 24 Holter EKG monitoring) of the patients
with and without type 2 diabetes mellitus are presented. It is shown, that in patients with 2 type
diabetes mellitus and especially in combination of diabetes with arterial hypertension, vasomotor
and productive activity of endothelium are seriously damaged. Indicated pathological findings are
dependent on homocysteine plasma level and in the part of patients with endothelium dysfunction
and homocysteine exchange violations the manifestations of ischemic heart disease are statistically
reliable frequently occurred. Thus, the endothelium dysfunction in patients with diabetes mellitus
type 2 especially in combination with arterial hypertension and high plasma homocysteine level can
be considered as prognostic markers of the hidden coronary insufficiency, which needs careful
monitoring of these patients condition and adequate additions to the traditional pharmacological
therapy.
E-mail: kamile.ceferova@mail.ru
R yçi: tibb ü.e.d., professor V. . zizov
|